Cargando…

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy

PURPOSE: Although mutational analysis of pancreatic cancer has provided valuable clinical information, it has not significantly changed treatment prospects. The purpose of this study is to further investigate molecular alterations in locally advanced pancreatic cancer and identify predictors of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Juan, Qiu, Xin, Lu, Changchang, Zhu, Yahui, Kong, Weiwei, Xu, Mian, Zhang, Xin, Tang, Min, Chen, Jun, Li, Qi, Li, Aimei, He, Jian, Gu, Qing, Wang, Lei, Qiu, Yudong, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157486/ https://www.ncbi.nlm.nih.gov/pubmed/35664782 http://dx.doi.org/10.3389/fonc.2022.844527

Ejemplares similares

Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer
por: Lu, Changchang, et al.
Publicado: (2022)

Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer
por: Lu, Changchang, et al.
Publicado: (2022)

AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 Study
por: Dai, Wangshu, et al.
Publicado: (2021)

Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
por: Shi, Zhan, et al.
Publicado: (2022)

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer
por: Du, Juan, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
por: Gong, Xiaoling, et al.
Publicado: (2022)

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
por: Qiu, Xin, et al.
Publicado: (2023)

PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial
por: Du, Juan, et al.
Publicado: (2023)

Global landscape of 2-hydroxyisobutyrylation in human pancreatic cancer
por: Lu, Yun, et al.
Publicado: (2022)

Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Jiang, Jiahong, et al.
Publicado: (2021)

Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer
por: Shen, Yanting, et al.
Publicado: (2021)

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2020)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Bao, Xuanwen, et al.
Publicado: (2019)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Intact glycopeptides identified by LC-MS/MS as biomarkers for response to chemotherapy of locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

A case report of surgical resection treatment for complete remission after chemotherapy for advanced pancreatic cancer
por: Zhang, Zhongyan, et al.
Publicado: (2023)

Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
por: Zhang, Yun-yu, et al.
Publicado: (2020)

The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Chen, Fang, et al.
Publicado: (2022)

Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review
por: Rizzo, Stefania, et al.
Publicado: (2022)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
por: Zhu, Lisheng, et al.
Publicado: (2021)

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

The Circumferential Resection Margin Is a Prognostic Predictor in Colon Cancer
por: Tang, Xin-Yi, et al.
Publicado: (2020)

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021)

The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database
por: Wu, Zhengqi, et al.
Publicado: (2022)

Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer
por: Zhu, Yue-Ting, et al.
Publicado: (2020)

The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients
por: Guo, Shiwei, et al.
Publicado: (2021)

A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy
por: Kong, Fanhao, et al.
Publicado: (2023)

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis
por: Cheng, Wanying, et al.
Publicado: (2023)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
por: Xing, Jiazhang, et al.
Publicado: (2021)

MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis
por: He, Guifang, et al.
Publicado: (2021)

Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer
por: Mao, Chenchen, et al.
Publicado: (2021)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy
por: Zhou, Zhenyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iblgdtqn9fg6an3lm6q61m0th2